Allergopharma GmbH & Co. KG

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites	immune system disorder	Not yet recruiting	Not stated	2025-07-31		NCT07096440
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study	Allergic Rhinoconjunctivitis	Recruiting	Phase 4	2025-01-28		NCT06778213

Clinical trials